Beneficiaries
- Ghent University, Belgium (www.ugent.be/en; www.debaerelab.com)
- Radboud University Medical Center Nijmegen, The Netherlands (www.ru.nl/donders/research/theme-2-perception-action-control/research-groups-theme-2/blindness-genetics/;www.ru.nl/donders/research/theme-2-perception-action-control/research-groups-theme-2/genetic-therapy-inherited-retinal-disease/)
- Eberhard Karls University Tubingen, Germany (www.eye-tuebingen.de/wissingerlab)
- Telethon Institute of Genetics and Medicine, Naples, Italy (www.telethon.it; www.tigem.it)
- University of Leeds, United Kingdom (medhealth.leeds.ac.uk/info/311/ophthalmology_and_neuroscience)
- Spanish National Research Council, Seville, Spain (www.csic.es; www.upo.es/CABD/GomezSkarmetaLab)
- Trinity College Dublin, Ireland (www.tcd.ie)
- University College London, United Kingdom (www.ucl.ac.uk)
- NewCells Biotech Ltd, Newcastle, United Kingdom (newcellsbiotech.co.uk)
- ProQR Therapeutics, Leiden, The Netherlands (www.proqr.com)
|
|
|
|
|
Partner Organisations
- Retina International, Switzerland (www.retina-international.org)
- Fighting Blindness, Ireland (www.fightingblindness.ie)
- 20Med Therapeutics, The Netherlands (20medtherapeutics.com)
- F. Hoffmann – La Roche Ltd., Switzerland (www.roche.com)
- European Vision Institute, Belgium (www.europeanvisioninstitute.org)
|
|
|
|
|
Partners
- Oogfonds, The Netherlands (www.oogfonds.nl)
|
